Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash

Comparison of Plasma Metabolites From Patients With Non-Small Cell Lung Cancer by Erlotinib Treatment and Skin Rash

Erlotinib is a necessary anticancer treatment for non-small cell lung cancer (NSCLC) patients yet it causes severe side effects such as skin rash. In this study, researchers compared the untargeted compound profiles before and after erlotinib administration to observe changes in blood metabolites in...

Full description

Bibliographic Details
Main Authors: Won Kil Lee PhD, Jisoo Myong KMD, PhD, Eunbin Kwag MS, Younmin Shin MS, Ji Woong Son MD, PhD, Byong Chul Yoo PhD, Byoung-Soo Kim KMD, PhD, Hwa-Seung Yoo KMD, PhD, Jeong June Choi PhD
Format: Article
Language:English
Published: SAGE Publishing 2023-09-01
Series:Integrative Cancer Therapies
Online Access:https://doi.org/10.1177/15347354231198090

Internet

https://doi.org/10.1177/15347354231198090

Similar Items